CHRISTOPHER MARTINEZ: Open Payments
NPI 1417561895 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 87 payments from 17 companies in 2025. Trend: 2023 $1,292 · 2024 $789 · 2025 $1,417
Food & beverage: $1,417
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $323 |
| Novo Nordisk Inc | 13 | $253 |
| PFIZER INC. | 23 | $209 |
| AstraZeneca Pharmaceuticals LP | 8 | $194 |
| Dexcom, Inc. | 4 | $73 |
| SANOFI-AVENTIS U.S. LLC | 3 | $70 |
| Lilly USA, LLC | 3 | $55 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
Products named: UBRELVY, NURTEC ODT, QULIPTA, Wegovy, FARXIGA, Dexcom G6 Transmitter, TZIELD, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
